ABSTRACT
Introduction: Haemorrhoids are the clinical manifestation of the downward disruption of normal functional architecture known as the anal cushion. A wide variety of treatment options are currently available for haemorrhoidal disease. For grade I & II of haemorrhoids, Minimal Invasive Procedures are done routinely in which Injection Sclerotherapy is included in this study. Methods: 150 patients presenting with Grade I & II haemorrhoids, admitted through the outpatient department, under General Surgery Department at our Hospital, who underwent Injection sclerotherapy between April 2019 to April 2022 were included. Objective: To study clinical presentation of patients with Grade I & II of haemorrhoides & sclerotherapy as a management modality. Results: Male gender and middle age group were predominant risk factors for haemorrhoides & sclerotherapy was found to be cost effective as well as compliant management modality. Conclusion: Injection Sclerotherapy is a day care procedure & is highly effective in treating Grade I and Grade II of haemorrhoids. It is economical, well accepted, well tolerated over other management modalities for haemorrhoids.